Literature DB >> 20639522

Estimating the diagnostic likelihood ratio of a continuous marker.

Wen Gu1, Margaret Sullivan Pepe.   

Abstract

The diagnostic likelihood ratio function, DLR, is a statistical measure used to evaluate risk prediction markers. The goal of this paper is to develop new methods to estimate the DLR function. Furthermore, we show how risk prediction markers can be compared using rank-invariant DLR functions. Various estimators are proposed that accommodate cohort or case-control study designs. Performances of the estimators are compared using simulation studies. The methods are illustrated by comparing a lung function measure and a nutritional status measure for predicting subsequent onset of major pulmonary infection in children suffering from cystic fibrosis. For continuous markers, the DLR function is mathematically related to the slope of the receiver operating characteristic (ROC) curve, an entity used to evaluate diagnostic markers. We show that our methodology can be used to estimate the slope of the ROC curve and illustrate use of the estimated ROC derivative in variance and sample size calculations for a diagnostic biomarker study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639522      PMCID: PMC3006125          DOI: 10.1093/biostatistics/kxq045

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  17 in total

Review 1.  The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

2.  Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes.

Authors:  Chaya S Moskowitz; Margaret S Pepe
Journal:  Biostatistics       Date:  2004-01       Impact factor: 5.899

3.  The analysis of placement values for evaluating discriminatory measures.

Authors:  Margaret Sullivan Pepe; Tianxi Cai
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

Review 4.  Receiver operating characteristic (ROC) methodology: the state of the art.

Authors:  J A Hanley
Journal:  Crit Rev Diagn Imaging       Date:  1989

5.  Standardizing diagnostic markers to evaluate and compare their performance.

Authors:  Margaret Sullivan Pepe; Gary Longton
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

6.  Estimating the capacity for improvement in risk prediction with a marker.

Authors:  Wen Gu; Margaret Sullivan Pepe
Journal:  Biostatistics       Date:  2008-08-19       Impact factor: 5.899

7.  Ruling out or ruling in disease with the most sensitive or specific diagnostic test: short cut or wrong turn?

Authors:  E J Boyko
Journal:  Med Decis Making       Date:  1994 Apr-Jun       Impact factor: 2.583

8.  Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Authors:  R J Knudson; M D Lebowitz; C J Holberg; B Burrows
Journal:  Am Rev Respir Dis       Date:  1983-06

9.  Estimation and Comparison of Receiver Operating Characteristic Curves.

Authors:  Margaret Pepe; Gary Longton; Holly Janes
Journal:  Stata J       Date:  2009-03-01       Impact factor: 2.637

10.  Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Authors:  Margaret S Pepe; Ziding Feng; Holly Janes; Patrick M Bossuyt; John D Potter
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

View more
  12 in total

1.  LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS.

Authors:  Ying Huang; Margaret S Pepe; Ziding Feng
Journal:  Ann Appl Stat       Date:  2013-09-01       Impact factor: 2.083

Review 2.  Biomarkers for posttransplantation outcomes.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

Review 3.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

Review 4.  Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.

Authors:  Sophie Paczesny
Journal:  Br J Haematol       Date:  2020-02-10       Impact factor: 6.998

Review 5.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

6.  Updating risk prediction tools: a case study in prostate cancer.

Authors:  Donna P Ankerst; Tim Koniarski; Yuanyuan Liang; Robin J Leach; Ziding Feng; Martin G Sanda; Alan W Partin; Daniel W Chan; Jacob Kagan; Lori Sokoll; John T Wei; Ian M Thompson
Journal:  Biom J       Date:  2011-11-17       Impact factor: 2.207

7.  Screening Accuracy of FeNO Measurement for Childhood Asthma in a Community Setting.

Authors:  Kamil Barański; Jan Eugeniusz Zejda
Journal:  Children (Basel)       Date:  2022-06-08

Review 8.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

9.  Likelihood ratios for glaucoma diagnosis using spectral-domain optical coherence tomography.

Authors:  Renato Lisboa; Kaweh Mansouri; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2013-08-20       Impact factor: 5.258

10.  Methods for identifying the cost-effective case definition cut-off for sequential monitoring tests: an extension of Phelps and Mushlin.

Authors:  Roberta Longo; Paul Baxter; Peter Hall; Jenny Hewison; Mehran Afshar; Geoff Hall; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.